AAAAAA

   
Results: 1-12 |
Results: 12
Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects
Authors: Rohatagi, S Gillen, M Aubeneau, M Jan, C Pandit, B Jensen, BK Rhodes, G
Citation: S. Rohatagi et al., Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects, INT J CL PH, 39(3), 2001, pp. 126-134
Pharmacokinetic-pharmacodynamic modeling of the antilipolytic effects of an adenosine receptor agonist in healthy volunteers
Authors: Zannikos, PN Rohatagi, S Jensen, BK
Citation: Pn. Zannikos et al., Pharmacokinetic-pharmacodynamic modeling of the antilipolytic effects of an adenosine receptor agonist in healthy volunteers, J CLIN PHAR, 41(1), 2001, pp. 61-69
Effect of food and gender on the pharmacokinetics of RP 73401, a phosphodiesterase IV inhibitor
Authors: Argenti, D Vaccaro, SK Shah, B Gillen, MS Rohatagi, S Jensen, BK
Citation: D. Argenti et al., Effect of food and gender on the pharmacokinetics of RP 73401, a phosphodiesterase IV inhibitor, INT J CL PH, 38(12), 2000, pp. 588-594
Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency
Authors: Zannikos, PN Jensen, BK Boutouyrie, BX Tripp, L Yongyi, L McGowan, T Waldman, SA Greenberg, HE
Citation: Pn. Zannikos et al., Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency, J CLIN PHAR, 40(7), 2000, pp. 745-751
A mass balance study to evaluate the biotransformation and excretion of [C-14]-triamcinolone acetonide following oral administration
Authors: Argenti, D Jensen, BK Hensel, R Bordeaux, K Schleimer, R Bickel, C Heald, D
Citation: D. Argenti et al., A mass balance study to evaluate the biotransformation and excretion of [C-14]-triamcinolone acetonide following oral administration, J CLIN PHAR, 40(7), 2000, pp. 770-780
Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients
Authors: Rohatagi, S Calic, F Harding, N Ozoux, ML Bouriot, JP Kirkesseli, S DeLeij, L Jensen, BK
Citation: S. Rohatagi et al., Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients, J CLIN PHAR, 40(11), 2000, pp. 1211-1226
Pharmacokinetics, pharmacodynamics, and safety of a platelet GPIIb/IIIa antagonist, RGD891, following intravenous administration in healthy male volunteers
Authors: Zannikos, PN Rohatagi, H Jensen, BK DePhillips, SL Massignon, D Calic, F Sibille, M Kirkesseli, S
Citation: Pn. Zannikos et al., Pharmacokinetics, pharmacodynamics, and safety of a platelet GPIIb/IIIa antagonist, RGD891, following intravenous administration in healthy male volunteers, J CLIN PHAR, 40(11), 2000, pp. 1245-1256
Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM)
Authors: Zannikos, PN Rohatagi, S Jensen, BK DePhillips, SL Rhodes, GR
Citation: Pn. Zannikos et al., Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM), J CLIN PHAR, 40(10), 2000, pp. 1129-1140
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: Results of theTIMI 15A and 15B trials
Authors: Giugliano, RP McCabe, CH Sequeira, RF Frey, MJ Henry, TD Piana, RN Tamby, JF Jensen, BK Nicolas, SB Jennings, LK Wise, RJ Braunwald, E
Citation: Rp. Giugliano et al., First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: Results of theTIMI 15A and 15B trials, AM HEART J, 140(1), 2000, pp. 81
High-frequency pressure fluctuations measured in heart valve patients
Authors: Paulsen, PK Jensen, BK Hasenkam, JM Nygaard, H
Citation: Pk. Paulsen et al., High-frequency pressure fluctuations measured in heart valve patients, J HEART V D, 8(5), 1999, pp. 482-486
Effects of food on the pharmacokinetics of sparfloxacin
Authors: Johnson, RD Dorr, MB Hunt, TL Jensen, BK Talbot, GH
Citation: Rd. Johnson et al., Effects of food on the pharmacokinetics of sparfloxacin, CLIN THER, 21(6), 1999, pp. 982-991
Pharmacokinetics, safety, and tolerability of single intravenous infusionsof an adenosine agonist, AMP 579, in healthy male volunteers
Authors: Zannikos, PN Baybutt, RI Boutouyrie, BX Shah, B Hunt, TL Jensen, BK
Citation: Pn. Zannikos et al., Pharmacokinetics, safety, and tolerability of single intravenous infusionsof an adenosine agonist, AMP 579, in healthy male volunteers, J CLIN PHAR, 39(10), 1999, pp. 1044-1052
Risultati: 1-12 |